Sunday, February 5, 2012
"The source for European pharmaceutical biotechnology news..."
How the minefield that is socia media could actually prove beneficial for the world of pharma.
Issue 8 Executive Interviews
Starting at phase zero
Michael Butler of Xceleron looks at the value a microdose study adds to a drug development programme.
No Comments
The future of biomarker assays
Ralph McDade of Rules Based Medicine explains why more is better when it comes to data used to identify meaningful biomaker patterns.
No Comments
Medical communications in a changing world
Amanda Smith of Caudex Medical explains the effects of the movement towards evidence-based medicine.
No Comments
Moving ahead in medical communications
David Swinbanks tells NGP about Nature Publishing Group’s recent move into medical communications with its new division, Macmillan Medical Communications.
No Comments
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.